Hemodynamically Significant Patent Ductus Arteriosus (HsPDA) in a Preterm Infant - An Innocent Bystander or a Predilection for Disaster?
- PMID: 37477862
- DOI: 10.1007/s12098-023-04767-7
Hemodynamically Significant Patent Ductus Arteriosus (HsPDA) in a Preterm Infant - An Innocent Bystander or a Predilection for Disaster?
Comment on
-
Cardiopulmonary Ultrasound-Guided Treatment of Premature Infants with Respiratory Failure and Patent Ductus Arteriosus: A Randomized, Controlled Trial.Indian J Pediatr. 2023 Nov;90(11):1103-1109. doi: 10.1007/s12098-023-04489-w. Epub 2023 Mar 23. Indian J Pediatr. 2023. PMID: 36952111 Clinical Trial.
References
-
- Smith A, EL-Khuffash A. Patent ductus arteriosus clinical trials: lessons learned and future directions. Child (Basel). 2021;8:47.
-
- Zhang Z, Lou X, Hua L, Jia X, Xu L, Zhao M. Cardiopulmonary ultrasound-guided treatment of premature infants with respiratory failure and patent ductus arteriosus: A randomized, controlled trial. Indian J Pediatr. 2023. https://doi.org/10.1007/s12098-023-04489-w .